The muscarinic M5 receptor:: a silent or emerging subtype?

被引:94
作者
Eglen, RM
Nahorski, SR
机构
[1] Roche Biosci, Biol Res Ctr, Neurobiol Unit, Palo Alto, CA 94304 USA
[2] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
关键词
M-5; receptors; receptor channelling; phosphoinositide hydrolysis; dopaminergic transmission; ciliary-iris muscle; salivary gland;
D O I
10.1038/sj.bjp.0703276
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:13 / 21
页数:9
相关论文
共 87 条
[1]  
Akam E. C., 1998, British Journal of Pharmacology, V125, p24P
[2]   Discovery & development of selective M(3) antagonists for clinical use [J].
Alabaster, VA .
LIFE SCIENCES, 1997, 60 (13-14) :1053-1060
[3]   MUSCARINIC POTENTIATION OF EXCITATORY AMINO ACID-EVOKED DOPAMINE RELEASE IN MESENCEPHALIC CELLS - SPECIFICITY FOR THE NMDA RESPONSE AND ROLE OF INTRACELLULAR MESSENGERS [J].
ALLAOUA, H ;
CHAUDIEU, I ;
ALONSO, R ;
QUIRION, R ;
BOKSA, P .
SYNAPSE, 1993, 15 (01) :39-47
[4]  
BERNSTEIN G, 1992, J BIOL CHEM, V267, P8081
[5]   Elementary and global aspects of calcium signalling [J].
Berridge, MJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 499 (02) :291-306
[6]   M2 MUSCARINIC RECEPTORS ON THE IRIS SPHINCTER MUSCLE DIFFER FROM THOSE ON IRIS NORADRENERGIC NERVES [J].
BOGNAR, IT ;
BAUMANN, B ;
DAMMANN, F ;
KNOLL, B ;
MEINCKE, M ;
PALLAS, S ;
FUDER, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (2-3) :263-274
[7]   A MUSCARINIC RECEPTOR DIFFERENT FROM THE M1, M2, M3 AND M4 SUBTYPES MEDIATES THE CONTRACTION OF THE RABBIT IRIS SPHINCTER [J].
BOGNAR, IT ;
ALTES, U ;
BEINHAUER, C ;
KESSLER, I ;
FUDER, H .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (06) :611-618
[8]   CLONING AND EXPRESSION OF THE HUMAN AND RAT M5 MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
YOUNG, AC ;
BRANN, MR ;
BUCKLEY, NJ .
NEURON, 1988, 1 (05) :403-410
[9]   Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells [J].
Bräuner-Osborne, H ;
Brann, MR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (01) :93-102
[10]  
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469